BACKGROUND: Different scoring systems have been developed to determine the severity of atopic dermatitis (AD); the SCORAD (Scoring Atopic Dermatitis) and EASI (Eczema Area and Severity Index) are among the best-validated scoring systems. OBJECTIVE: The aim of this study was to produce a rational quality control for routine clinical use by using the modern facilities of digital imaging. METHODS: 63 AD patients were scored by a single person at each visit using the SCORAD and EASI scoring methods. Images were taken and rated by two non-dermatology physicians trained in the scoring system. In addition, blood samples were taken for the determination of total IgE, eosinophils and eosinophilic cationic protein. RESULTS: The EASI score established from the digital images, hereby named 'EASIdig', correlated at all visits with the results of the SCORAD and EASI. Together with immunological parameters, they also reflected changes of disease severity during the 3 time points. CONCLUSION: The digital evaluation of the EASI is a reliable tool for the digital assessment of severity and extent of AD.
BACKGROUND: Different scoring systems have been developed to determine the severity of atopic dermatitis (AD); the SCORAD (Scoring Atopic Dermatitis) and EASI (Eczema Area and Severity Index) are among the best-validated scoring systems. OBJECTIVE: The aim of this study was to produce a rational quality control for routine clinical use by using the modern facilities of digital imaging. METHODS: 63 ADpatients were scored by a single person at each visit using the SCORAD and EASI scoring methods. Images were taken and rated by two non-dermatology physicians trained in the scoring system. In addition, blood samples were taken for the determination of total IgE, eosinophils and eosinophilic cationic protein. RESULTS: The EASI score established from the digital images, hereby named 'EASIdig', correlated at all visits with the results of the SCORAD and EASI. Together with immunological parameters, they also reflected changes of disease severity during the 3 time points. CONCLUSION: The digital evaluation of the EASI is a reliable tool for the digital assessment of severity and extent of AD.
Authors: Emily A Croce; Paul J Rathouz; Fabiana C P S Lopes; Maria Leszczynska; Lucia Z Diaz; Moise L Levy; Jennifer S Ruth; Pooja Varshney; Lynn Rew; Elizabeth C Matsui Journal: Pediatr Dermatol Date: 2022-05-06 Impact factor: 1.997
Authors: Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg Journal: J Invest Dermatol Date: 2021-08-02 Impact factor: 8.551